378 related articles for article (PubMed ID: 16353949)
21. Impact of psychostimulants on vesicular monoamine transporter function.
Fleckenstein AE; Hanson GR
Eur J Pharmacol; 2003 Oct; 479(1-3):283-9. PubMed ID: 14612158
[TBL] [Abstract][Full Text] [Related]
22. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
Seger D
Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328
[TBL] [Abstract][Full Text] [Related]
23. The dopamine transporter: a vigilant border control for psychostimulant action.
Williams JM; Galli A
Handb Exp Pharmacol; 2006; (175):215-32. PubMed ID: 16722238
[TBL] [Abstract][Full Text] [Related]
24. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants.
Buck KJ; Amara SG
Mol Pharmacol; 1995 Dec; 48(6):1030-7. PubMed ID: 8848002
[TBL] [Abstract][Full Text] [Related]
25. Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.
Ribeiro P; Patocka N
Parasitol Int; 2013 Dec; 62(6):629-38. PubMed ID: 23800409
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives.
Simmler LD; Rickli A; Schramm Y; Hoener MC; Liechti ME
Biochem Pharmacol; 2014 Mar; 88(2):237-44. PubMed ID: 24486525
[TBL] [Abstract][Full Text] [Related]
27. The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters.
Maier J; Mayer FP; Luethi D; Holy M; Jäntsch K; Reither H; Hirtler L; Hoener MC; Liechti ME; Pifl C; Brandt SD; Sitte HH
Neuropharmacology; 2018 Aug; 138():282-291. PubMed ID: 29908239
[TBL] [Abstract][Full Text] [Related]
28. Monoamine transporters: from genes to behavior.
Gainetdinov RR; Caron MG
Annu Rev Pharmacol Toxicol; 2003; 43():261-84. PubMed ID: 12359863
[TBL] [Abstract][Full Text] [Related]
29. Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.
Bermingham DP; Blakely RD
Pharmacol Rev; 2016 Oct; 68(4):888-953. PubMed ID: 27591044
[TBL] [Abstract][Full Text] [Related]
30. A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.
Robertson SD; Matthies HJ; Galli A
Mol Neurobiol; 2009 Apr; 39(2):73-80. PubMed ID: 19199083
[TBL] [Abstract][Full Text] [Related]
31. Proteins interacting with monoamine transporters: current state and future challenges.
Sager JJ; Torres GE
Biochemistry; 2011 Aug; 50(34):7295-310. PubMed ID: 21797260
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic potential of monoamine transporter substrates.
Rothman RB; Baumann MH
Curr Top Med Chem; 2006; 6(17):1845-59. PubMed ID: 17017961
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology of Drugs Used as Stimulants.
Docherty JR; Alsufyani HA
J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S53-S69. PubMed ID: 34396557
[TBL] [Abstract][Full Text] [Related]
34. Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.
Howell LL; Negus SS
Adv Pharmacol; 2014; 69():129-76. PubMed ID: 24484977
[TBL] [Abstract][Full Text] [Related]
35. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G
Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607
[TBL] [Abstract][Full Text] [Related]
36. New insights into the mechanism of action of amphetamines.
Fleckenstein AE; Volz TJ; Riddle EL; Gibb JW; Hanson GR
Annu Rev Pharmacol Toxicol; 2007; 47():681-98. PubMed ID: 17209801
[TBL] [Abstract][Full Text] [Related]
37. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.
Bottalico B; Larsson I; Brodszki J; Hernandez-Andrade E; Casslén B; Marsál K; Hansson SR
Placenta; 2004 Jul; 25(6):518-29. PubMed ID: 15135235
[TBL] [Abstract][Full Text] [Related]
38. Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy.
Daws LC
Pharmacol Ther; 2009 Jan; 121(1):89-99. PubMed ID: 19022290
[TBL] [Abstract][Full Text] [Related]
39. Uncovering Functional Contributions of PMAT (
Beaver JN; Weber BL; Ford MT; Anello AE; Kassis SK; Gilman TL
Cells; 2022 Jun; 11(12):. PubMed ID: 35741002
[TBL] [Abstract][Full Text] [Related]
40. Neurotransmitter and psychostimulant recognition by the dopamine transporter.
Wang KH; Penmatsa A; Gouaux E
Nature; 2015 May; 521(7552):322-7. PubMed ID: 25970245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
